leadforensics

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

PHARMA REPORT

rss_Pharma.jpg...see all
Global Infectious Disease Diagnostics Market Forecast 2017-2027

Global Infectious Disease Diagnostics Market Forecast 2017-2027

Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography

Product code: PHA0243

  • Publication date: 27/09/2017
  • Number of Pages: 142
  1. Report Details
  2. Table of Contents
  3. Companies Listed

Report Details

Infectious Disease Diagnostics – our new study reveals trends, R&D progress, and predicted revenues
Where is the Infectious Disease Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 142-page report provides 83 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Infectious Disease Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the infectious disease diagnostics market, with forecasts for 5 Diseases, 4 Techniques and 3 End Users, each forecasted at a global level.

Global Infectious Disease Diagnostic Market by Disease Type
• HIV/AIDS
• Hepatitis
• Tuberculosis
• Malaria
• Chlamydia

Global Infectious Disease Diagnostic Market by Technique
• Immunoassay
• Molecular Diagnostics
• POC/Rapid Diagnosis
• Microbiology

Global Infectious Disease Diagnostic Market by End User
• Hospitals
• Clinical Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 11 leading national markets:
• US
• Germany
• The UK
• Italy
• Spain
• France
• Japan
• Brazil
• China
• India
• Russia

Global Infectious Disease Diagnostics Market Forecast 2017-2027

The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Infectious Disease Diagnostics will surpass $13bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Infectious Disease Diagnostics Market report helps you
In summary, our 142-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the Infectious Disease Diagnostics market, with forecasts for 5 Disease Types, 4 Techniques and 3 End Users – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 11 key national markets – See forecasts for the infectious disease diagnostics market in the US, Brazil, Germany, France, the UK, Italy, Spain, China, India, Russia and Japan
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
– including company profiles for 9 of the major companies involved in the Infectious Disease Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Infectious Disease Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Table of Contents

1. Report Overview
1.1 Global Infectious Disease Diagnostics Market Overview
1.2 Global Infectious Disease Diagnostics Market Segmentation
1.3 Infectious Disease Diagnostics Report Structure
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. The Global Infectious Disease Diagnostics Market (Disease Type) 2017-2027
2.1 An Introduction to Major Types of Infectious Diseases
2.2 HIV/AIDS
2.2.1 Antibody tests
2.2.2 Combination tests (Antigen/Antibody tests)
2.2.3 Nucleic Acid Tests (NATS)
2.3 Hepatitis
2.3.1 Enzyme test
2.3.2 Viral antibodies
2.4 Tuberculosis
2.5 Malaria
2.6 Chlamydia

3. The Global Infectious Disease Diagnostics Market (Technique) 2017-2027
3.1 An introduction to various types of techniques
3.2 Immunoassay
3.3 Molecular Diagnostics
3.4 Point of care/ rapid diagnosis
3.5 Microbiology
3.5.1 Culture
3.5.2 Microbial identification
3.6 Market Shares by Segment, 2017 and 2027
3.7 World Infectious Disease Diagnostics Market: Forecast by technique 2017-2027

4. The Global Infectious Disease Diagnostics Market (End User) 2017-2027
4.1 An introduction to end users
4.2 Hospitals
4.3 Clinical Laboratories
4.4 Others
4.5 Market Shares by end users, 2017-2027

5. The Global Infectious Disease Diagnostics Market (Geography) 2017-2027
5.1 An Introduction to the Infectious Disease Diagnostics Market by geography
5.2 United States Infectious Disease Diagnostics Market
5.2.1 United States Infectious Disease Diagnostics Market: by disease type
5.2.2 United States Infectious Disease Diagnostics Market: by end user
5.3 EU-5 Infectious Disease Diagnostics Market
5.3.1 EU-5 Infectious Disease Diagnostics Market: by disease type
5.3.2 EU-5 Infectious Disease Diagnostics Market: by End User
5.3.3 EU-5 Infectious Disease Diagnostics Market: by Country
5.3.3.1 Germany
5.3.3.2 France
5.3.3.3 United Kingdom
5.3.3.4 Spain
5.3.3.5 Italy
5.4 Japan Infectious Disease Diagnostics Market
5.4.1 Japan Infectious Disease Diagnostics Market: by disease type
5.4.2 Japan Infectious Disease Diagnostics Market: by End User
5.5 BRIC Infectious Disease Diagnostics Market
5.5.1 BRIC Infectious Disease Diagnostics Market: by disease type
5.5.2 BRIC Infectious Disease Diagnostics Market: by End User
5.5.3 BRIC Infectious Disease Diagnostics Market: by country
5.5.3.1 Brazil
5.5.3.2 India
5.5.3.3 Russia
5.5.3.4 China

6. Leading Companies in Infectious Disease Diagnostics Market
6.1 Introduction
6.2 Abbott Laboratories
6.2.1.1 Business Overview
6.2.1.2 Recent Financials
6.2.1.3 Product Offerings
6.2.1.4 Recent developments
6.3 Becton, Dickinson and Company
6.3.1.1 Business Overview
6.3.1.2 Recent Financials
6.3.1.3 Product Offerings
6.3.1.4 Recent developments
6.4 Biomérieux
6.4.1.1 Business Overview
6.4.1.2 Recent Financials
6.4.1.3 Product Offerings
6.4.1.4 Recent developments
6.5 Bio-Rad Laboratories
6.5.1.1 Business Overview
6.5.1.2 Recent Financials
6.5.1.3 Product Offerings
6.5.1.4 Recent developments
6.6 Alere, Inc
6.6.1.1 Business Overview
6.6.1.2 Recent Financials
6.6.1.3 Product Offerings
6.6.1.4 Recent developments
6.7 Siemens Healthcare
6.7.1.1 Business Overview
6.7.1.2 Recent Financials
6.7.1.3 Product Offerings
6.7.1.4 Recent Developments
6.8 Roche Diagnostics
6.8.1.1 Business Overview
6.8.1.2 Recent Financials
6.8.1.3 Product Offerings
6.8.1.4 Recent Developments
6.9 Danaher Corporation
6.9.1.1 Business Overview
6.9.1.2 Recent Financials:
6.9.1.3 Product and Service Offerings
6.9.1.4 Recent developments
6.10 Thermo-Fisher Scientific, Inc.
6.10.1.1 Recent Financials
6.10.1.2 Product Offerings
6.10.1.3 Recent Developments
6.11 Other Players of Importance within the Global Infectious Disease Diagnostics Industry

7. Qualitative Analysis
7.1 Porter’s Five Forces Analysis
7.1.1 Bargaining Power of Buyers
7.1.2 Bargaining Power of Suppliers
7.1.3 Industry Rivalry
7.1.4 Threat of New Entrants
7.1.5 Threat of Substitutes

8. Conclusion and Recommendation
8.1 Key Take-Away
8.2 Conclusion

9. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form

List of Figures
Figure 2.1 Prevalence of HIV/Aids In Major Countries
Figure 2.2 Incidence Of Hiv Across Various Countries
Figure 2.3 Incidence of Hepatitis Forecast (2017-2027)
Figure 2.4 Forecasted Cases Of Tuberculosis (2017-2027)
Figure 2.5 Forecasted Cases Of Malaria (2017-2027)
Figure 2.6 Forecasted Cases Of Chlamydia (2017-2027)
Figure 3.1 Percentage Contribution Of Individual Segment- 2017
Figure 3.2 Percentage Contribution Of Individual Segment- 2027
Figure 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, 2017-2027
Figure 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.5 Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.1.: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.2: Global Infectious Disease Diagnostics end user: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 4.4: Infectious Disease Diagnostics End-User Market Share (%) 2017
Figure 4.5: Infectious Disease Diagnostics End-User Market Share (%) 2027
Figure 5.1. Infectious Disease Diagnostics Market, Regional Market Share, 2017 (%)
Figure 5.2. Infectious Disease Diagnostics Market, Regional Market Share, 2027 (%)
Figure 5.3: US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR %) 2017-2027
Figure 5.4: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Figure 5.5: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.6: EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR %) 2017-2027
Figure 5.7. Infectious Disease Diagnostics market, Disease cases, 2017-2027, EU-5
Figure 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.9: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.10: Japanese Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.11. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Figure 5.12: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 5.13: BRIC Infectious Disease Diagnostics Market Forecast, By Market (Revenue, $bn, AGR %) 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn) 2017-2027
Figure 7.1 Porter’s Five Forces Analysis for the Infectious Disease Diagnostics Market

List of Tables
Table 2.1 Prevalence Forecast of HIV/AIDS in major countries (Mn, 2017-2027)
Table 2.2 Incidence of HIV across various countries (2017-2027)
Table 2.3 Incidence of Hepatitis Forecast (2017-2027)
Table 2.4 Forecasted Incidence Of Tuberculosis (2017-2027)
Table 2.5 Forecasted Incidences of Malaria (2017-2027)
Table 2.6 Incidences of Chlamydia (2017-2027)
Table 3.1 infectious disease diagnoses By Share (%, 2017)
Table 3.2 infectious disease diagnoses By Share (%, 2027)
Table 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, and CAGR %, 2017-2027
Table 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.5: Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.1: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.2: Global Infectious Disease Diagnostics: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.1 : Infectious Disease Diagnostics Market Forecast, (Geographical Distribution, $bn, AGR %) 2017-2027
Table 5.2 : US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.3: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Table 5.4: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.5 : EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.6: EU-5 Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
Table 5.7: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.9. Japanese Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.10. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Table 5.11: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.12: BRIC Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.13 : BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Table 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 6.1 Abbott Laboratories– Key Facts
Table 6.2 Abbott Recent Financials
Table 6.3 Becton, Dickinson and Company– Key Facts
Table 6.4 Becton, Dickinson and Company Recent Financials
Table 6.5 bioMérieux S.A. – Key Facts
Table 6.6 bioMérieux S.A.Recent Financials
Table 6.7 Bio-Rad – Key Facts
Table 6.8 Bio-Rad – Recent Financials
Table 6.9 Alere – Key Facts
Table 6.10 Alere – Recent Financials
Table 6.11 Siemens Healthcare – Key Facts
Table 6.12 Siemens Healthcare – Recent Financials
Table 6.13 Roche Diagnostics – Key Facts
Table 6.14 Danaher Corporation– Key Facts
Table 6.15 Danaher Corporation.– Recent Financials
Table 6.16 Thermo Fisher Scientific Inc.– Key Facts
Table 6.17 Thermo Fisher Scientific Inc.– Recent Financials
Table 6.18: Companies of interest in the Infectious Disease Diagnostics Market

Companies Listed

3M
Abaxis
Abaxis Inc
Abbott Laboratories
Advanced Care
Affymetrix, Inc.
AgaMatrix
Agendia BV
Alere Health Systems Inc.
Amgenix International Inc
Arkay
Ascensia Diabetes Care
Astra Zeneca
AutoGenomics, Inc.
Avioq, Inc.
B Braun
Bayer
BBI Helathcare
Becton Dickinson
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
Biofire Diagnostics
BioLytical Laboratories
Bionime
Bio-Rad Laboratories
Biosense Medical
BioSign
Biosite Diagnostics
Biosynex Medtech
Boehringer Ingelheim
Calypte Biomedical
Celera Diagnostics
Cepheid
Cerus Corporation
Chembio Diagnostic Systems
Cholestech
Church & Dwight
Clinical Micro Sensors, Inc.
Concateno
Core Diagnostics
CVS/Pharmacy
Dako Denmark A/S
DakoCytomation Denmark A/S
Dario Health
Decision Diagnostics Corp.
Dexcom
Diabetic Supply of Suncoast
Diagnostic Devices
DiME
Early Pregnancy Tests.com
EKF Diagnostics
Entra Helath Systems
Exact Sciences Corporation
EY Laboratories
Fenwal Inc
Fifty50 Medical
Focus Diagnostics
ForaCare
Fujirebio
Genentech
General Life Biotechnology Ltd
Genesis Health Technology
GenMark Diagnostics
Gen-Probe, Inc.
Genzyme
Gluco Com
Grove Instruments
Halifax
Helena Laboratories
Hema technologies
Hologic, Inc.
Home Access Health Corporation
Horiba
IHelath Labs
Illumina, Inc.
IME-DC
IND Diagnostic Inc.
Infopia
Insight Pharmaceuticals
Instrumentation Laboratory (a company of Werfen Group)
InTec Products
Integrity Applications Ltd.
International Technidyne Corporation
Inverness Medical
Iris Molecular Diagnostics
JANT Pharmacal Corporation
Johnson & Johnson
LifeScan
Livongo Health
Luminex Molecular Diagnostics, Inc.
Marnes La Coquette
Maxim Biomedical Inc
Medford
Medix Biochemica
Medor
Menarini
Meridian Bioscience
Mitsubishi Chemical
MIZUHO MEDY Company
Myriad Genetic Laboratories, Inc.
Nani Daman
Nanosphere, Inc.
Nanostring Technologies
Nipro Diadnostics
Nova Diabetes
Oak Tree Health
Oak Tree International Holdings
Omnis Health
One Drop
OraSure Technologies
Orgenics
OrSense NBM-200G
Ortho-Clinical Diagnostics, Inc.
Osmetech Molecular Diagnostics
ParagonDx, LLC
Partec
Pathwork Diagnostics Inc.
Pharma Tech Solutions
Philosys
POC Medical System
PointCare Technologies
Polymer Technology Systems Inc
Premier Medical Corporation
Princeton Biomedtech
Procter & Gamble
Prodigy Diabetes Care
Proteome Systems
Quest Diagnostics
Quidel
Remel/Thermofisher
Response Biomedical Corporation
Roche Diagnostics Corporation
Roche Molecular Systems, Inc.
RunBio Biotech Company
SA Scientific
Sanofi
Siemens Healthcare Diagnostics GmbH
Spartan Bioscience, Inc.
Spirit Healthcare
Standard Diagnostics Inc.
Swiss Precision Diagnostics
Symphony
Sysmex
Telcare
Thermo Fisher Scientific
Third Wave Technologies Inc.
Tm Bioscience Corporation
TrimGen Corporation
Trinity Biotech
Trividia Health
Trovagene
U.S. Diagnostics
Unimed International
Universal Biosensors
Universal Diagnostics
Ventana Medical Systems, Inc.
Veridex, LLC.
Vysis
WellDoc Corporation
xDx Inc.
YD Diagnostics

List of Organizations
Australian Institute Of Health And Welfare
European Medicines Agency
Food Drug and Administration
Health Canada
Ministry of Health, Labor and Welfare
National Cancer Institute
The American Society Of Clinical Oncology Inc
The Feinstein Institute For Medical Research
United States Department Of Health & Human Services
World Health Organization

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close